In-vitro Diagnostics Market Worth $133.34 Billion, Globally, by 2027 at 5.1% CAGR: Verified Market Research

JERSEY CITY, New Jersey, June 24, 2020 /PRNewswire/ -- Verified Market Research recently published a report, "In-vitro Diagnostics Market by Application (Diabetes, Infectious Diseases, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing or Pharmacogenomics, HIV/AIDS), by End User (Laboratories, Hospitals, Academics, Point-Of-Care Testing, Patient Self-Testing), by Technology (Immunochemistry and Immunoassay,  Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis), by Product & Service (Reagents and Kits, Instruments, Data Management Software, Services))". According to Verified Market Research, the Global In-vitro Diagnostics Market was valued at USD 89.60 Billion in 2019 and is projected to reach USD 133.34 Billion by 2027, growing at a CAGR of 5.1% from 2020 to 2027.

This report provides detailed analysis of the growth trends among each of the segments as well as accurate forecasts in terms of the value and volume.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=42365

Browse in-depth TOC on "In-vitro Diagnostics Market"

248- Pages
198 – Tables
41 – Figures

Global In-vitro Diagnostics Market Overview

The increased frequency of infectious diseases and chronic diseases and the rise in geriatric populace is the crucial factor responsible for the growth in the market. The World Health Organization has summoned the onset of the global crisis. Infectious diseases kill over 17 million people a year. The increased call for fully automated instrumentation in laboratories is fueling market growth. Automation is the utilization of electronics and computer-controlled devices to regulate the process. The goal of automation is to enhance efficacy and dependability.

In most cases, automation replaces labor workforce. Today, economists fear that new technology will cause a surge in the unemployment rates significantly. Test automation software is a convenient way to increase the effectiveness and coverage of your software testing. The automated tests are created; they can be repetitive and can be extended to perform tasks impossible with manual testing. The Miura, by ISE Diagnostic Systems, is a completed automated analyzer for Clinical Chemistry, operating in the upper segment of mid-sized laboratories. The increased consciousness about the use of personalized medicine is gaining traction. It is a unique method to tailor disease prevention and treatment that takes into account differences in people's genes, environments, and lifestyles. The goal of precision medicine is to target the right therapies to the right patients at the right time.

Advances in precision medicine have already led to discoveries and FDA-approved treatments that are custom-made to specific characteristics of individuals, such as a person's genetic makeup. The significance of companion diagnostic will pave the way for lucrative opportunities in the market. It is an in-vitro medical device, which delivers information that is essential for safe and reliable use of a similar biological product. The BRAC Analysis CDx is used to cure breast cancer and has been approved by the FDA.  The major players in the market are Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company, Biomérieux Sa, Bio-Rad Laboratories, Inc., Johnson & Johnson.

Verified Market Research has segmented In-vitro Diagnostics Market on the basis of Product & Services, Technology, End User, Application & Geography.

• In-vitro Diagnostics Market by Application
• Diabetes
• Infectious Diseases
• Oncology
• Cardiology
• Nephrology
• Autoimmune Diseases
• Drug Testing or Pharmacogenomics
• HIV/AIDS

• In-vitro Diagnostics Market by End User
• Laboratories
• Hospitals
• Academics
• Point-Of-Care Testing
• Patient Self-Testing

• In-vitro Diagnostics Market by Product & Service
• Reagents and Kits
• Instruments
• Data Management Software
• Services

• In-vitro Diagnostics Market by Geographic Scope
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

In Vitro Lung Model Market by Type (2D Cell Models, 3D Cell Models), by Application (Drug Screening, Toxicology, 3D Model Development), by Geographic Scope, Forecast, 2019-2026

In Vitro Toxicology Testing Market by Toxicity end point and test results (ADME (Absorption, Distribution, Metabolism, and Excretion), Skin Irritation, Corrosion, and Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, Carcinogenicity, Neurotoxicity), by Technology (Cell Culture Technologies, High-Throughput Technologies, Cellular Imaging Technologies, Toxicogenomics), by Method, by Industry, by Products and Services, Geography, Forecast, 2020-2027

In Vitro Diagnostics (IVD) Quality Control Market by Product (Serum/Plasma-based products, Whole blood-based products, Urine based products), by Application (Immunochemistry, Clinical Chemistry, Hematology, Molecular Diagnostics, Coagulation/Hemostasis, Microbiology), by End User, Geography, Forecast, 2020-2027

Stable Isotope Labeled Compounds Market by Type (Deuterium, Oxygen-18, Carbon-13, and Nitrogen-15), by End-Use (Research Institutes, Pharmaceutical & Biopharmaceutical, and Others), Geography, Forecast, 2020-2027

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (203)-411-9686
APAC: +91 (902)-863-5784
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Photo: https://mma.prnewswire.com/media/1195834/In_Vitro_Diagnostics_Market.jpg
Logo: https://mma.prnewswire.com/media/1170750/Verified_Market_Research_Logo.jpg